www.avicanna.com
Open in
urlscan Pro
144.208.70.212
Public Scan
URL:
http://www.avicanna.com/
Submission: On December 07 via api from US — Scanned from DE
Submission: On December 07 via api from US — Scanned from DE
Form analysis 1 forms found in the DOM
POST
<form id="mc4wp-form-1" class="mc4wp-form mc4wp-form-9589" method="post" data-id="9589" data-name="Avicanna.com">
<div class="mc4wp-form-fields">
<p>
<label>
<input type="email" name="EMAIL" placeholder="Enter your email address" required=""> <input type="submit" value="Sign up">
</label>
</p>
</div><label style="display: none !important;">Leave this field empty if you’re human: <input type="text" name="_mc4wp_honeypot" value="" tabindex="-1" autocomplete="off"></label><input type="hidden" name="_mc4wp_timestamp"
value="1670382067"><input type="hidden" name="_mc4wp_form_id" value="9589"><input type="hidden" name="_mc4wp_form_element_id" value="mc4wp-form-1">
<div class="mc4wp-response"></div>
</form>Text Content
Skip to content * About * About * People * R&D * Cultivation * Investors * Investor Relations * News and Press * Portfolio * Aureus Santa Marta * Pura H&W * re+PLAY * Rho Phyto * TruneroxTM * Viola * Academy * Contact * About * About * People * R&D * Cultivation * Investors * Investor Relations * News and Press * Portfolio * Aureus Santa Marta * Pura H&W * re+PLAY * Rho Phyto * TruneroxTM * Viola * Academy * Contact Instagram Twitter Linkedin Facebook-f Twitter Instagram * About * About * People * R&D * Cultivation * Investors * Investor Relations * News and Press * Portfolio * Aureus Santa Marta * Pura H&W * re+PLAY * Rho Phyto * TruneroxTM * Viola * Academy * Contact × * About * About * People * R&D * Cultivation * Investors * Investor Relations * News and Press * Portfolio * Aureus Santa Marta * Pura H&W * re+PLAY * Rho Phyto * TruneroxTM * Viola * Academy * Contact DRIVING BIOPHARMACEUTICAL ADVANCEMENTS OF PLANT-DERIVED CANNABINOID-BASED PRODUCTS At the MaRS Discovery District Toronto WHO WE ARE Avicanna is a Canadian commercial-stage biopharmaceutical company Leading in cannabinoid research, development, and evidence-based products for the global consumer medical and pharmaceutical segments. Play Video Avicanna 2022 Corporate Video CORPORATE OVERVIEW Global commercialization strategy with diversified & high margin income streams across 12+ countries. Comprehensive commercial portfolio Consumer, medical cannabis and cannabinoid supply chain Multinational sales with international footprint USA, Canada, Europe and LATAM Revenue generation and scale up phase 3 consecutive Q-Q growth of minimum 30% Proven scientific platform, including R&D, pre-clinical and clinical infrastructure in Canada Cannabinoid drug development pipeline 30+ advanced commercial SKUs + pharmaceutical pipeline World-renowned collaborations with leading Canadian academic and clinical institutions JLABS @ Toronto, Johnson & Johnson Innovation Centre R&D headquarters in the MaRS Discovery District Established and environmentally sustainable low-cost vertical integration in Colombia Two Colombian majority-owned subsidiaries cultivation footprint of 480,000 sq feet with industrial extraction capacity World-renowned collaborations with leading Canadian academic and clinical institutions Organic and sustainable cultivation ranked highest amongst global cannabis companies in a corporate sustainability assessment – issued by S&P Global in 2020 OUR PORTFOLIO Avicanna’s scientific platform has resulted in 30+ commercial and proprietary formulations and products Including cosmetics, medical cannabis, pharmaceuticals in addition to its raw material business unit across international markets Commercial Stage Medical Cannabis and Wellness Products Commercial Stage CBD Dermacosmetics Consumer Retail Products In Development and Registration Stage Pharmaceutical Pipeline Commercial Stage Cannabinoid API & Seeds INDUSTRY LEADING SCIENTIFIC PLATFORM Setting the Standard in the Cannabinoid Industry on Advanced and Evidence-Based Products ESTABLISHED RESEARCH & DEVELOPMENT PLATFORM Setting the Standard in the Cannabinoid Industry with Advanced and Evidence Based Product R&D headquarters at JLABS @ Toronto, Johnson & Johnson Innovation Centre in the MaRS Discovery District Drug development pipeline, including sustained release tablets, transdermal patches and nano participle formulations 30+ Commercial stage proprietary products 10+ Scientists 7+ Canadian Government research grants awarded since 2020 8+ Pending Patents 4+ Health Canada cannabis R&D licenses issued to Avicanna and its academic collaborators WORLD-CLASS COLLABORATIONS R&D and Clinical Partnerships Over the Past 4 Years WORLD-CLASS COLLABORATIONS R&D and clinical collaborations with world-class academic and medical institutes since 2016 Majority of the research has been conducted in Canada through 4 Health Canada cannabis R&D licenses issued to Avicanna and its academic collaborators. MaRS Discovery District University Health Network Hospital of Sick Children University of Guelph JLABS @ Toronto University of Toronto Sunnybrook Health Science Centre Thompson Rivers University CLINICAL DEVELOPMENT Setting the Standard in the Cannabinoid Industry on Advanced and Evidence-Based Products 08.08.2021 PRODUCTS & PIPELINE Serving the Global Marketplace with Proprietary Advanced Cannabinoid-Based Products CONTACT * info@avicanna.com * info.latam@avicanna.com PORTFOLIO HEADQUARTERS Toronto, Canada 480 University Ave, Suite 1502 Toronto, ON M5G 1V2 Canada CORPORATE TSX: AVCN OTCQX: AVCNF FSE: 0NN GLOBAL OFFICES Bogota, Colombia Avicanna Latam S.A.S. Carrera 15 #88-21, Oficina 702 Torre Unika Virrey Santa Marta, Colombia Avicanna Latam S.A.S. Edificio Bahía Centro Cra. 1 #22-58, Oficina 903 Santa Marta – Magdalena London, United Kingdom Avicanna (UK) Limited Tallis House 2 Tallis Street, Temple London, EC4Y 0AB United Kingdom Avicanna USA Inc. 200 South Biscayne Boulevard Miami FL 33131 SOCIAL * @Avicanna Inc. (TSX:AVCN) * @avicanna * @avicannainc * @avicannaInc * @avicanna NEWSLETTER SIGN-UP Leave this field empty if you’re human: © 2017-2021 Avicanna Inc. All Rights Reserved.